Syros Pharmaceuticals (SYRS)
(Delayed Data from NSDQ)
$5.36 USD
-0.29 (-5.13%)
Updated May 22, 2024 04:00 PM ET
After-Market: $5.38 +0.02 (0.37%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $-0.77 | 5.60% |
Earnings Summary
For their last quarter, Syros Pharmaceuticals (SYRS) reported earnings of -$0.79 per share, beating the Zacks Consensus Estimate of $-0.89 per share. This reflects a positive earnings surprise of 11.24%. Look out for SYRS's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of -$0.77 per share, reflecting a year-over-year increase of 40.77%.
Earnings History
Price & Consensus
Zacks News for SYRS
Will Femasys Inc. (FEMY) Report Negative Q1 Earnings? What You Should Know
SYRS: What are Zacks experts saying now?
Zacks Private Portfolio Services